Inclusion Criteria:

• Signed informed consent
•  Male or female patients, 18 to 75 years of age
• Confirmed clinico-pathological diagnosis of eosinophilic esophagitis (EoE) according to established diagnostic criteria
• Active symptomatic and histological EoE
• Negative pregnancy test in females of childbearing potential at baseline visit

Exclusion Criteria:

• Clinical and endoscopic signs of gastroesophageal reflux disease (GERD)
• Achalasia, scleroderma esophagus, or systemic sclerosis
• Other clinically evident causes than EoE for esophageal eosinophilia
• Any concomitant esophageal disease and relevant gastro-intestinal disease (celiac disease, inflammatory bowel disease, oropharyngeal or esophageal bacterial, viral, or fungal infection [candida esophagitis])
• Any relevant systemic disease (e.g., AIDS, active tuberculosis, hepatitis B or C)
• If careful medical monitoring is not ensured: cardiovascular disease, diabetes mellitus, osteoporosis, active peptic ulcer disease, glaucoma, cataract, or infection
• Liver cirrhosis or portal hypertension
• History of cancer in the last five years
• History of esophageal surgery at any time or of esophageal dilation procedures within the last 4 weeks prior to screening visit, or need for an immediate endoscopic intervention due to a stricture
• Upper gastrointestinal bleeding within 8 weeks prior to baseline visit
• Existing or intended pregnancy or breast-feeding.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/16/2024. Questions regarding updates should be directed to the study team contact.